Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Prospective Study Evaluating the Impact and Treatment of Thrombo-embolic Events in Patients With Cancer"

NCT03826043 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.

NCT NCT03826043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03826043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Prospective Study Evaluating the Impact and Treatment of Thrombo-embolic Events in Patients With Cancer"
Lead sponsor
Centre Antoine Lacassagne
Phase
Not applicable
Overall status
Completed
Start date
September 9, 2019
Completion date
September 9, 2022
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, neoplasms, thrombosis